Tolgabide
From Wikipedia, the free encyclopedia
Clinical data | |
---|---|
ATC code | none |
Legal status | |
Legal status |
|
Identifiers | |
|
|
CAS Number | 86914-11-6 |
PubChem (CID) | 5748792 |
ChemSpider | 14917033 |
UNII | 0L55QF645F |
KEGG | D06181 |
ChEMBL | CHEMBL2104937 |
Chemical and physical data | |
Formula | C18H18Cl2N2O2 |
Molar mass | 365.25 g/mol |
3D model (Jmol) | Interactive image |
|
|
|
Tolgabide INN (SL-81.0142) is a drug which was patented by Synthélabo as an anticonvulsant but was never marketed.[1] It is an analogue of progabide and acts similarly to it as a prodrug of GABA, and therefore as an indirect agonist of the GABA receptors.[1][2]
Synthesis[edit]
See also[edit]
References[edit]
- ^ a b David J. Triggle (1996). Dictionary of Pharmacological Agents. Boca Raton: Chapman & Hall/CRC. ISBN 0-412-46630-9.
- ^ "The use of common stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances" (PDF). 2002.